JP6175428B2 - 細菌のポリシストロン性発現系 - Google Patents

Info

Publication number

JP6175428B2

JP6175428B2 JP2014513212A JP2014513212A JP6175428B2 JP 6175428 B2 JP6175428 B2 JP 6175428B2 JP 2014513212 A JP2014513212 A JP 2014513212A JP 2014513212 A JP2014513212 A JP 2014513212A JP 6175428 B2 JP6175428 B2 JP 6175428B2

Authority

JP

Japan

Prior art keywords

gram

gene

promoter

endogenous

exogenous

Prior art date

2011-06-01

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Active

Links

• Espacenet
• Global Dossier
• Discuss

• 230000014509 gene expression Effects 0.000 title claims description 322
• 230000001580 bacterial effect Effects 0.000 title description 15
• 108090000623 proteins and genes Proteins 0.000 claims description 767
• 241000894006 Bacteria Species 0.000 claims description 210
• 102000004169 proteins and genes Human genes 0.000 claims description 142
• 108091029795 Intergenic region Proteins 0.000 claims description 131
• 241000192125 Firmicutes Species 0.000 claims description 128
• 241000194035 Lactococcus lactis Species 0.000 claims description 111
• 150000007523 nucleic acids Chemical class 0.000 claims description 102
• 102000039446 nucleic acids Human genes 0.000 claims description 99
• 108020004707 nucleic acids Proteins 0.000 claims description 99
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 74
• 235000014897 Streptococcus lactis Nutrition 0.000 claims description 68
• 239000012634 fragment Substances 0.000 claims description 61
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 59
• 101150045855 rpmD gene Proteins 0.000 claims description 59
• 229920001184 polypeptide Polymers 0.000 claims description 52
• 239000013598 vector Substances 0.000 claims description 49
• 241000194031 Enterococcus faecium Species 0.000 claims description 47
• JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 42
• 101150115929 Usp45 gene Proteins 0.000 claims description 38
• 230000001225 therapeutic effect Effects 0.000 claims description 28
• 101150047850 rplN gene Proteins 0.000 claims description 27
• 101100363550 Leptospira borgpetersenii serovar Hardjo-bovis (strain L550) rpsE2 gene Proteins 0.000 claims description 26
• 101100254826 Methanopyrus kandleri (strain AV19 / DSM 6324 / JCM 9639 / NBRC 100938) rps5 gene Proteins 0.000 claims description 26
• 101150027173 rpsE gene Proteins 0.000 claims description 26
• 101150053568 rplP gene Proteins 0.000 claims description 25
• 101150036652 GAPB gene Proteins 0.000 claims description 21
• 108010021625 Immunoglobulin Fragments Proteins 0.000 claims description 21
• 102000008394 Immunoglobulin Fragments Human genes 0.000 claims description 21
• 210000000349 chromosome Anatomy 0.000 claims description 21
• 239000004310 lactic acid Substances 0.000 claims description 21
• 235000014655 lactic acid Nutrition 0.000 claims description 21
• 101100010747 Escherichia coli (strain K12) epd gene Proteins 0.000 claims description 20
• 101150098454 GAPA2 gene Proteins 0.000 claims description 20
• 101100335749 Halobacterium salinarum (strain ATCC 700922 / JCM 11081 / NRC-1) gap gene Proteins 0.000 claims description 20
• 101150015255 rplB gene Proteins 0.000 claims description 19
• 101150036132 rpsG gene Proteins 0.000 claims description 19
• 239000000427 antigen Substances 0.000 claims description 18
• 108091007433 antigens Proteins 0.000 claims description 18
• 102000036639 antigens Human genes 0.000 claims description 18
• 241000194036 Lactococcus Species 0.000 claims description 17
• 101150021143 rplW gene Proteins 0.000 claims description 17
• 101150078442 RPL5 gene Proteins 0.000 claims description 16
• 101150083684 rplE gene Proteins 0.000 claims description 16
• 101150104526 rplM gene Proteins 0.000 claims description 16
• 101100037096 Methanococcus maripaludis (strain S2 / LL) rpl6 gene Proteins 0.000 claims description 15
• 239000008194 pharmaceutical composition Substances 0.000 claims description 15
• 101150034310 rplF gene Proteins 0.000 claims description 15
• 230000002759 chromosomal effect Effects 0.000 claims description 14
• 230000000069 prophylactic effect Effects 0.000 claims description 13
• 239000003814 drug Substances 0.000 claims description 12
• 230000001939 inductive effect Effects 0.000 claims description 12
• 241000194033 Enterococcus Species 0.000 claims description 11
• 101150001987 rplS gene Proteins 0.000 claims description 10
• 101150040440 rpmB gene Proteins 0.000 claims description 10
• 101150081398 rpmB1 gene Proteins 0.000 claims description 10
• 241000186000 Bifidobacterium Species 0.000 claims description 9
• 102000037865 fusion proteins Human genes 0.000 claims description 9
• 108020001507 fusion proteins Proteins 0.000 claims description 9
• 230000036039 immunity Effects 0.000 claims description 9
• 230000002865 vaccinogenic effect Effects 0.000 claims description 8
• 108010003723 Single-Domain Antibodies Proteins 0.000 claims description 7
• 241000186660 Lactobacillus Species 0.000 claims description 6
• 102000012288 Phosphopyruvate Hydratase Human genes 0.000 claims description 5
• 108010022181 Phosphopyruvate Hydratase Proteins 0.000 claims description 5
• 230000006058 immune tolerance Effects 0.000 claims description 5
• 229940039696 lactobacillus Drugs 0.000 claims description 5
• 235000018102 proteins Nutrition 0.000 description 89
• 230000027455 binding Effects 0.000 description 56
• 108700026244 Open Reading Frames Proteins 0.000 description 48
• 210000004027 cell Anatomy 0.000 description 46
• 229960003115 certolizumab pegol Drugs 0.000 description 46
• 230000000694 effects Effects 0.000 description 43
• 230000028327 secretion Effects 0.000 description 40
• 239000000047 product Substances 0.000 description 39
• 241000699670 Mus sp. Species 0.000 description 37
• 108091026890 Coding region Proteins 0.000 description 35
• 108091033319 polynucleotide Proteins 0.000 description 33
• 102000040430 polynucleotide Human genes 0.000 description 33
• 102000053187 Glucuronidase Human genes 0.000 description 28
• 108010060309 Glucuronidase Proteins 0.000 description 28
• 238000000034 method Methods 0.000 description 27
• IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 26
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 26
• 239000013612 plasmid Substances 0.000 description 26
• 238000011282 treatment Methods 0.000 description 26
• 101000889443 Homo sapiens Trefoil factor 1 Proteins 0.000 description 24
• 102000051048 human TFF1 Human genes 0.000 description 24
• 230000001105 regulatory effect Effects 0.000 description 24
• 230000014616 translation Effects 0.000 description 24
• 241001465754 Metazoa Species 0.000 description 23
• 108020004705 Codon Proteins 0.000 description 22
• 101150033625 enoA gene Proteins 0.000 description 22
• 238000013518 transcription Methods 0.000 description 22
• 230000035897 transcription Effects 0.000 description 22
• 101100437498 Escherichia coli (strain K12) uidA gene Proteins 0.000 description 21
• 201000010099 disease Diseases 0.000 description 21
• 238000013519 translation Methods 0.000 description 21
• 101150015836 ENO1 gene Proteins 0.000 description 19
• 101001128431 Homo sapiens Myeloid-derived growth factor Proteins 0.000 description 19
• 238000005119 centrifugation Methods 0.000 description 19
• 102000056374 human MYDGF Human genes 0.000 description 19
• 230000010354 integration Effects 0.000 description 19
• 239000006228 supernatant Substances 0.000 description 19
• 241000193163 Clostridioides difficile Species 0.000 description 18
• 102000004127 Cytokines Human genes 0.000 description 18
• 108090000695 Cytokines Proteins 0.000 description 18
• 108700039887 Essential Genes Proteins 0.000 description 18
• 101001033233 Homo sapiens Interleukin-10 Proteins 0.000 description 18
• 230000009977 dual effect Effects 0.000 description 18
• 102000052620 human IL10 Human genes 0.000 description 18
• 238000011002 quantification Methods 0.000 description 18
• 238000002965 ELISA Methods 0.000 description 17
• 241000588724 Escherichia coli Species 0.000 description 17
• 101000611183 Homo sapiens Tumor necrosis factor Proteins 0.000 description 17
• 239000012228 culture supernatant Substances 0.000 description 17
• 238000004519 manufacturing process Methods 0.000 description 17
• 210000003578 bacterial chromosome Anatomy 0.000 description 16
• 239000000203 mixture Substances 0.000 description 16
• 230000003472 neutralizing effect Effects 0.000 description 16
• 239000002773 nucleotide Substances 0.000 description 15
• 125000003729 nucleotide group Chemical group 0.000 description 15
• 210000001072 colon Anatomy 0.000 description 14
• 230000002503 metabolic effect Effects 0.000 description 14
• DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 13
• 241000699800 Cricetinae Species 0.000 description 13
• 108010076504 Protein Sorting Signals Proteins 0.000 description 13
• IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 13
• 238000003780 insertion Methods 0.000 description 13
• 230000037431 insertion Effects 0.000 description 13
• 244000005700 microbiome Species 0.000 description 13
• 230000003248 secreting effect Effects 0.000 description 13
• 241000894007 species Species 0.000 description 13
• 229940104230 thymidine Drugs 0.000 description 13
• 108010076181 Proinsulin Proteins 0.000 description 12
• 108091081024 Start codon Proteins 0.000 description 12
• 230000006801 homologous recombination Effects 0.000 description 12
• 238000002744 homologous recombination Methods 0.000 description 12
• 210000001519 tissue Anatomy 0.000 description 12
• 238000001727 in vivo Methods 0.000 description 11
• 108020004999 messenger RNA Proteins 0.000 description 11
• 239000000546 pharmaceutical excipient Substances 0.000 description 11
• 239000000843 powder Substances 0.000 description 11
• 101100427060 Bacillus spizizenii (strain ATCC 23059 / NRRL B-14472 / W23) thyA1 gene Proteins 0.000 description 10
• 101100153154 Escherichia phage T5 thy gene Proteins 0.000 description 10
• 108091028043 Nucleic acid sequence Proteins 0.000 description 10
• 101100313751 Rickettsia conorii (strain ATCC VR-613 / Malish 7) thyX gene Proteins 0.000 description 10
• 101710084578 Short neurotoxin 1 Proteins 0.000 description 10
• 101710182223 Toxin B Proteins 0.000 description 10
• 101710182532 Toxin a Proteins 0.000 description 10
• 102100040247 Tumor necrosis factor Human genes 0.000 description 10
• 230000002414 glycolytic effect Effects 0.000 description 10
• 101150072314 thyA gene Proteins 0.000 description 10
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
• WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 9
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 9
• 108010001336 Horseradish Peroxidase Proteins 0.000 description 9
• 108010059993 Vancomycin Proteins 0.000 description 9
• 206010009887 colitis Diseases 0.000 description 9
• 230000002068 genetic effect Effects 0.000 description 9
• 239000008103 glucose Substances 0.000 description 9
• 229920006395 saturated elastomer Polymers 0.000 description 9
• 210000002966 serum Anatomy 0.000 description 9
• 230000002103 transcriptional effect Effects 0.000 description 9
• MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 description 9
• 229960003165 vancomycin Drugs 0.000 description 9
• MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 9
• NHJVRSWLHSJWIN-UHFFFAOYSA-N 2,4,6-trinitrobenzenesulfonic acid Chemical compound OS(=O)(=O)C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O NHJVRSWLHSJWIN-UHFFFAOYSA-N 0.000 description 8
• 101100325760 Arabidopsis thaliana BAM9 gene Proteins 0.000 description 8
• 108020004414 DNA Proteins 0.000 description 8
• 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 8
• 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 8
• 230000001147 anti-toxic effect Effects 0.000 description 8
• 238000013459 approach Methods 0.000 description 8
• 230000003115 biocidal effect Effects 0.000 description 8
• 230000004071 biological effect Effects 0.000 description 8
• 230000012010 growth Effects 0.000 description 8
• 238000000338 in vitro Methods 0.000 description 8
• 238000002347 injection Methods 0.000 description 8
• 239000007924 injection Substances 0.000 description 8
• 101150015622 pyk gene Proteins 0.000 description 8
• 238000011144 upstream manufacturing Methods 0.000 description 8
• 241000193403 Clostridium Species 0.000 description 7
• 241000282412 Homo Species 0.000 description 7
• 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 7
• 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 7
• 102100036705 Interleukin-23 subunit alpha Human genes 0.000 description 7
• 241000699666 Mus <mouse, genus> Species 0.000 description 7
• 108020001027 Ribosomal DNA Proteins 0.000 description 7
• 230000037396 body weight Effects 0.000 description 7
• 229960002227 clindamycin Drugs 0.000 description 7
• KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 7
• 230000006378 damage Effects 0.000 description 7
• 238000009472 formulation Methods 0.000 description 7
• 230000004927 fusion Effects 0.000 description 7
• 102000057041 human TNF Human genes 0.000 description 7
• 239000002324 mouth wash Substances 0.000 description 7
• 150000003839 salts Chemical class 0.000 description 7
• 239000011734 sodium Substances 0.000 description 7
• 239000000243 solution Substances 0.000 description 7
• RBMGJIZCEWRQES-DKWTVANSSA-N (2s)-2,4-diamino-4-oxobutanoic acid;hydrate Chemical compound O.OC(=O)[C@@H](N)CC(N)=O RBMGJIZCEWRQES-DKWTVANSSA-N 0.000 description 6
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 6
• 102100021943 C-C motif chemokine 2 Human genes 0.000 description 6
• 101710155857 C-C motif chemokine 2 Proteins 0.000 description 6
• 102000019034 Chemokines Human genes 0.000 description 6
• 108010012236 Chemokines Proteins 0.000 description 6
• 241000194032 Enterococcus faecalis Species 0.000 description 6
• 241001495410 Enterococcus sp. Species 0.000 description 6
• 241000283086 Equidae Species 0.000 description 6
• WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 6
• 241000178948 Lactococcus sp. Species 0.000 description 6
• ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
• 241000283973 Oryctolagus cuniculus Species 0.000 description 6
• 230000008901 benefit Effects 0.000 description 6
• 230000015572 biosynthetic process Effects 0.000 description 6
• 239000000872 buffer Substances 0.000 description 6
• 238000012217 deletion Methods 0.000 description 6
• 230000037430 deletion Effects 0.000 description 6
• LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 6
• 229940032049 enterococcus faecalis Drugs 0.000 description 6
• 238000011553 hamster model Methods 0.000 description 6
• 230000000968 intestinal effect Effects 0.000 description 6
• 230000000670 limiting effect Effects 0.000 description 6
• 229940051866 mouthwash Drugs 0.000 description 6
• 239000002953 phosphate buffered saline Substances 0.000 description 6
• 102000005962 receptors Human genes 0.000 description 6
• 108020003175 receptors Proteins 0.000 description 6
• 230000009467 reduction Effects 0.000 description 6
• 230000004083 survival effect Effects 0.000 description 6
• 239000003053 toxin Substances 0.000 description 6
• 231100000765 toxin Toxicity 0.000 description 6
• 108700012359 toxins Proteins 0.000 description 6
• 101150101900 uidA gene Proteins 0.000 description 6
• 229960005486 vaccine Drugs 0.000 description 6
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
• 241000282472 Canis lupus familiaris Species 0.000 description 5
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 5
• 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 5
• 239000002671 adjuvant Substances 0.000 description 5
• 150000001413 amino acids Chemical class 0.000 description 5
• 238000004458 analytical method Methods 0.000 description 5
• 208000035475 disorder Diseases 0.000 description 5
• 239000013604 expression vector Substances 0.000 description 5
• 239000000499 gel Substances 0.000 description 5
• 238000011065 in-situ storage Methods 0.000 description 5
• 208000015181 infectious disease Diseases 0.000 description 5
• 210000000936 intestine Anatomy 0.000 description 5
• 210000000214 mouth Anatomy 0.000 description 5
• -1 promoter Proteins 0.000 description 5
• 230000001681 protective effect Effects 0.000 description 5
• 229940116176 remicade Drugs 0.000 description 5
• 210000002784 stomach Anatomy 0.000 description 5
• 239000000758 substrate Substances 0.000 description 5
• 230000014621 translational initiation Effects 0.000 description 5
• 239000003981 vehicle Substances 0.000 description 5
• QRXMUCSWCMTJGU-UHFFFAOYSA-N 5-bromo-4-chloro-3-indolyl phosphate Chemical compound C1=C(Br)C(Cl)=C2C(OP(O)(=O)O)=CNC2=C1 QRXMUCSWCMTJGU-UHFFFAOYSA-N 0.000 description 4
• 241000283707 Capra Species 0.000 description 4
• 238000011537 Coomassie blue staining Methods 0.000 description 4
• 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 4
• 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 4
• 241000792859 Enema Species 0.000 description 4
• 241000282326 Felis catus Species 0.000 description 4
• 108700039691 Genetic Promoter Regions Proteins 0.000 description 4
• 108060003951 Immunoglobulin Proteins 0.000 description 4
• 108010076561 Interleukin-23 Subunit p19 Proteins 0.000 description 4
• 108090001005 Interleukin-6 Proteins 0.000 description 4
• 108010085220 Multiprotein Complexes Proteins 0.000 description 4
• 102000007474 Multiprotein Complexes Human genes 0.000 description 4
• 206010028980 Neoplasm Diseases 0.000 description 4
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 4
• 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 4
• 239000008186 active pharmaceutical agent Substances 0.000 description 4
• 239000003153 chemical reaction reagent Substances 0.000 description 4
• 238000004737 colorimetric analysis Methods 0.000 description 4
• 238000010276 construction Methods 0.000 description 4
• 238000013270 controlled release Methods 0.000 description 4
• 230000001419 dependent effect Effects 0.000 description 4
• 238000010586 diagram Methods 0.000 description 4
• 229940088679 drug related substance Drugs 0.000 description 4
• 239000007920 enema Substances 0.000 description 4
• 210000001035 gastrointestinal tract Anatomy 0.000 description 4
• 210000003405 ileum Anatomy 0.000 description 4
• 102000018358 immunoglobulin Human genes 0.000 description 4
• 230000005764 inhibitory process Effects 0.000 description 4
• 230000000977 initiatory effect Effects 0.000 description 4
• 238000012423 maintenance Methods 0.000 description 4
• 238000006386 neutralization reaction Methods 0.000 description 4
• 230000001717 pathogenic effect Effects 0.000 description 4
• 239000013641 positive control Substances 0.000 description 4
• 238000002360 preparation method Methods 0.000 description 4
• 238000000746 purification Methods 0.000 description 4
• 230000002829 reductive effect Effects 0.000 description 4
• 239000000126 substance Substances 0.000 description 4
• CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
• 102000002260 Alkaline Phosphatase Human genes 0.000 description 3
• 108020004774 Alkaline Phosphatase Proteins 0.000 description 3
• 101100398412 Arabidopsis thaliana ASK1 gene Proteins 0.000 description 3
• 241000283690 Bos taurus Species 0.000 description 3
• 241000282465 Canis Species 0.000 description 3
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
• 108091033380 Coding strand Proteins 0.000 description 3
• 208000011231 Crohn disease Diseases 0.000 description 3
• 206010012735 Diarrhoea Diseases 0.000 description 3
• 102000004190 Enzymes Human genes 0.000 description 3
• 108090000790 Enzymes Proteins 0.000 description 3
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
• 206010061218 Inflammation Diseases 0.000 description 3
• 102000014150 Interferons Human genes 0.000 description 3
• 108010050904 Interferons Proteins 0.000 description 3
• 102000013462 Interleukin-12 Human genes 0.000 description 3
• 108010065805 Interleukin-12 Proteins 0.000 description 3
• 102000014158 Interleukin-12 Subunit p40 Human genes 0.000 description 3
• 108010011429 Interleukin-12 Subunit p40 Proteins 0.000 description 3
• 102000013691 Interleukin-17 Human genes 0.000 description 3
• 108050003558 Interleukin-17 Proteins 0.000 description 3
• 108010065637 Interleukin-23 Proteins 0.000 description 3
• 108010066979 Interleukin-27 Proteins 0.000 description 3
• 102100036678 Interleukin-27 subunit alpha Human genes 0.000 description 3
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
• 108091034117 Oligonucleotide Proteins 0.000 description 3
• 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 3
• 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 3
• 108091000080 Phosphotransferase Proteins 0.000 description 3
• CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 3
• 102000007641 Trefoil Factors Human genes 0.000 description 3
• 108010007389 Trefoil Factors Proteins 0.000 description 3
• 239000013566 allergen Substances 0.000 description 3
• 239000003242 anti bacterial agent Substances 0.000 description 3
• 230000000903 blocking effect Effects 0.000 description 3
• 230000036760 body temperature Effects 0.000 description 3
• 201000011510 cancer Diseases 0.000 description 3
• 239000002775 capsule Substances 0.000 description 3
• 229910052799 carbon Inorganic materials 0.000 description 3
• KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
• 230000004186 co-expression Effects 0.000 description 3
• 150000001875 compounds Chemical class 0.000 description 3
• 230000008878 coupling Effects 0.000 description 3
• 238000010168 coupling process Methods 0.000 description 3
• 238000005859 coupling reaction Methods 0.000 description 3
• 238000010790 dilution Methods 0.000 description 3
• 239000012895 dilution Substances 0.000 description 3
• 239000002552 dosage form Substances 0.000 description 3
• 238000012377 drug delivery Methods 0.000 description 3
• 229940095399 enema Drugs 0.000 description 3
• 238000005516 engineering process Methods 0.000 description 3
• 229940088598 enzyme Drugs 0.000 description 3
• 238000011156 evaluation Methods 0.000 description 3
• 238000011049 filling Methods 0.000 description 3
• 230000006870 function Effects 0.000 description 3
• 101150073818 gap gene Proteins 0.000 description 3
• 239000008187 granular material Substances 0.000 description 3
• 239000000411 inducer Substances 0.000 description 3
• 230000002757 inflammatory effect Effects 0.000 description 3
• 230000004054 inflammatory process Effects 0.000 description 3
• 229940079322 interferon Drugs 0.000 description 3
• 239000008101 lactose Substances 0.000 description 3
• 230000003902 lesion Effects 0.000 description 3
• 230000001404 mediated effect Effects 0.000 description 3
• 239000000178 monomer Substances 0.000 description 3
• 239000013642 negative control Substances 0.000 description 3
• 239000006186 oral dosage form Substances 0.000 description 3
• 230000008520 organization Effects 0.000 description 3
• 102000013415 peroxidase activity proteins Human genes 0.000 description 3
• 108040007629 peroxidase activity proteins Proteins 0.000 description 3
• 102000020233 phosphotransferase Human genes 0.000 description 3
• 239000002157 polynucleotide Substances 0.000 description 3
• 230000000770 proinflammatory effect Effects 0.000 description 3
• 230000009465 prokaryotic expression Effects 0.000 description 3
• 230000006798 recombination Effects 0.000 description 3
• 238000005215 recombination Methods 0.000 description 3
• 230000002441 reversible effect Effects 0.000 description 3
• 239000000523 sample Substances 0.000 description 3
• 210000000813 small intestine Anatomy 0.000 description 3
• 230000001629 suppression Effects 0.000 description 3
• 238000013268 sustained release Methods 0.000 description 3
• 239000012730 sustained-release form Substances 0.000 description 3
• 230000002195 synergetic effect Effects 0.000 description 3
• 238000003786 synthesis reaction Methods 0.000 description 3
• 239000003826 tablet Substances 0.000 description 3
• 230000003612 virological effect Effects 0.000 description 3
• 102100024341 10 kDa heat shock protein, mitochondrial Human genes 0.000 description 2
• 108020005065 3' Flanking Region Proteins 0.000 description 2
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 2
• 108020005029 5' Flanking Region Proteins 0.000 description 2
• 241000271566 Aves Species 0.000 description 2
• 241000186018 Bifidobacterium adolescentis Species 0.000 description 2
• 241001134770 Bifidobacterium animalis Species 0.000 description 2
• 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 description 2
• 241000186016 Bifidobacterium bifidum Species 0.000 description 2
• 241000186012 Bifidobacterium breve Species 0.000 description 2
• 241000186011 Bifidobacterium catenulatum Species 0.000 description 2
• 241001495388 Bifidobacterium choerinum Species 0.000 description 2
• 241000186022 Bifidobacterium coryneforme Species 0.000 description 2
• 241000186021 Bifidobacterium cuniculi Species 0.000 description 2
• 241000186020 Bifidobacterium dentium Species 0.000 description 2
• 241001312346 Bifidobacterium gallicum Species 0.000 description 2
• 241001608472 Bifidobacterium longum Species 0.000 description 2
• 241000186015 Bifidobacterium longum subsp. infantis Species 0.000 description 2
• 241000186150 Bifidobacterium minimum Species 0.000 description 2
• 108010046080 CD27 Ligand Proteins 0.000 description 2
• 108010029697 CD40 Ligand Proteins 0.000 description 2
• 102100032937 CD40 ligand Human genes 0.000 description 2
• 102100025221 CD70 antigen Human genes 0.000 description 2
• 241000206594 Carnobacterium Species 0.000 description 2
• 102000014914 Carrier Proteins Human genes 0.000 description 2
• 241000700198 Cavia Species 0.000 description 2
• 241001413544 Clostridioides difficile B-1 Species 0.000 description 2
• 206010009900 Colitis ulcerative Diseases 0.000 description 2
• FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
• 238000001712 DNA sequencing Methods 0.000 description 2
• 208000004232 Enteritis Diseases 0.000 description 2
• 241000283074 Equus asinus Species 0.000 description 2
• 108700024394 Exon Proteins 0.000 description 2
• 108010068561 Fructose-Bisphosphate Aldolase Proteins 0.000 description 2
• 241000233866 Fungi Species 0.000 description 2
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
• 101001057504 Homo sapiens Interferon-stimulated gene 20 kDa protein Proteins 0.000 description 2
• 101001055144 Homo sapiens Interleukin-2 receptor subunit alpha Proteins 0.000 description 2
• 101100207070 Homo sapiens TNFSF8 gene Proteins 0.000 description 2
• MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
• 102000003814 Interleukin-10 Human genes 0.000 description 2
• 108090000174 Interleukin-10 Proteins 0.000 description 2
• 102000014154 Interleukin-12 Subunit p35 Human genes 0.000 description 2
• 108010011301 Interleukin-12 Subunit p35 Proteins 0.000 description 2
• 102000004554 Interleukin-17 Receptors Human genes 0.000 description 2
• 108010017525 Interleukin-17 Receptors Proteins 0.000 description 2
• 102000003810 Interleukin-18 Human genes 0.000 description 2
• 108090000171 Interleukin-18 Proteins 0.000 description 2
• 102100026878 Interleukin-2 receptor subunit alpha Human genes 0.000 description 2
• 102100036672 Interleukin-23 receptor Human genes 0.000 description 2
• 102000004890 Interleukin-8 Human genes 0.000 description 2
• 108090001007 Interleukin-8 Proteins 0.000 description 2
• 108091092195 Intron Proteins 0.000 description 2
• 108700025703 Lactococcus lactis usp45 Proteins 0.000 description 2
• 101710157814 Lysozyme P Proteins 0.000 description 2
• 241000124008 Mammalia Species 0.000 description 2
• 229930195725 Mannitol Natural products 0.000 description 2
• 241000699673 Mesocricetus auratus Species 0.000 description 2
• 101100207071 Mus musculus Tnfsf8 gene Proteins 0.000 description 2
• 208000001132 Osteoporosis Diseases 0.000 description 2
• 241001311537 Parascardovia denticolens Species 0.000 description 2
• ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
• 241000700159 Rattus Species 0.000 description 2
• 108700008625 Reporter Genes Proteins 0.000 description 2
• 102000002278 Ribosomal Proteins Human genes 0.000 description 2
• 108010000605 Ribosomal Proteins Proteins 0.000 description 2
• 241001311541 Scardovia inopinata Species 0.000 description 2
• 101710130585 Secreted 45 kDa protein Proteins 0.000 description 2
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
• PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
• 102100032100 Tumor necrosis factor ligand superfamily member 8 Human genes 0.000 description 2
• 108090000848 Ubiquitin Proteins 0.000 description 2
• 102000044159 Ubiquitin Human genes 0.000 description 2
• 201000006704 Ulcerative Colitis Diseases 0.000 description 2
• 241000700605 Viruses Species 0.000 description 2
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
• 230000004913 activation Effects 0.000 description 2
• 229940024606 amino acid Drugs 0.000 description 2
• 235000001014 amino acid Nutrition 0.000 description 2
• 238000000137 annealing Methods 0.000 description 2
• 229940088710 antibiotic agent Drugs 0.000 description 2
• 230000000890 antigenic effect Effects 0.000 description 2
• 239000002585 base Substances 0.000 description 2
• 108010005774 beta-Galactosidase Proteins 0.000 description 2
• 108091008324 binding proteins Proteins 0.000 description 2
• 230000031018 biological processes and functions Effects 0.000 description 2
• 230000030833 cell death Effects 0.000 description 2
• 210000002421 cell wall Anatomy 0.000 description 2
• MYPYJXKWCTUITO-KIIOPKALSA-N chembl3301825 Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)C(O)[C@H](C)O1 MYPYJXKWCTUITO-KIIOPKALSA-N 0.000 description 2
• 238000002512 chemotherapy Methods 0.000 description 2
• 238000003776 cleavage reaction Methods 0.000 description 2
• 238000010367 cloning Methods 0.000 description 2
• 230000001332 colony forming effect Effects 0.000 description 2
• 230000000139 costimulatory effect Effects 0.000 description 2
• 239000002577 cryoprotective agent Substances 0.000 description 2
• 210000004748 cultured cell Anatomy 0.000 description 2
• 230000009089 cytolysis Effects 0.000 description 2
• 230000034994 death Effects 0.000 description 2
• 238000013461 design Methods 0.000 description 2
• 238000011161 development Methods 0.000 description 2
• 230000018109 developmental process Effects 0.000 description 2
• 238000004090 dissolution Methods 0.000 description 2
• 238000002474 experimental method Methods 0.000 description 2
• 230000002550 fecal effect Effects 0.000 description 2
• 235000013305 food Nutrition 0.000 description 2
• 102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 2
• 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 2
• 230000034659 glycolysis Effects 0.000 description 2
• PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
• 230000009931 harmful effect Effects 0.000 description 2
• 230000001744 histochemical effect Effects 0.000 description 2
• 229910052739 hydrogen Inorganic materials 0.000 description 2
• 231100001039 immunological change Toxicity 0.000 description 2
• 238000011534 incubation Methods 0.000 description 2
• 230000006698 induction Effects 0.000 description 2
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
• 230000003914 insulin secretion Effects 0.000 description 2
• 230000003834 intracellular effect Effects 0.000 description 2
• 238000011813 knockout mouse model Methods 0.000 description 2
• 210000002429 large intestine Anatomy 0.000 description 2
• 231100000225 lethality Toxicity 0.000 description 2
• 239000007788 liquid Substances 0.000 description 2
• HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
• 210000004962 mammalian cell Anatomy 0.000 description 2
• 239000000594 mannitol Substances 0.000 description 2
• 235000010355 mannitol Nutrition 0.000 description 2
• 239000011159 matrix material Substances 0.000 description 2
• 238000002156 mixing Methods 0.000 description 2
• 238000012986 modification Methods 0.000 description 2
• 230000004048 modification Effects 0.000 description 2
• 229960003816 muromonab-cd3 Drugs 0.000 description 2
• 210000004940 nucleus Anatomy 0.000 description 2
• 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 description 2
• 230000036961 partial effect Effects 0.000 description 2
• 244000052769 pathogen Species 0.000 description 2
• 231100000915 pathological change Toxicity 0.000 description 2
• 230000001575 pathological effect Effects 0.000 description 2
• 210000001322 periplasm Anatomy 0.000 description 2
• 230000035479 physiological effects, processes and functions Effects 0.000 description 2
• 229920000642 polymer Polymers 0.000 description 2
• 230000019525 primary metabolic process Effects 0.000 description 2
• 238000001243 protein synthesis Methods 0.000 description 2
• 238000000575 proteomic method Methods 0.000 description 2
• 239000002994 raw material Substances 0.000 description 2
• 238000003753 real-time PCR Methods 0.000 description 2
• 238000003259 recombinant expression Methods 0.000 description 2
• 238000011084 recovery Methods 0.000 description 2
• 210000000664 rectum Anatomy 0.000 description 2
• 230000010076 replication Effects 0.000 description 2
• 230000003362 replicative effect Effects 0.000 description 2
• 101150008233 rplU gene Proteins 0.000 description 2
• 230000007017 scission Effects 0.000 description 2
• 238000012163 sequencing technique Methods 0.000 description 2
• 125000006850 spacer group Chemical group 0.000 description 2
• 238000010186 staining Methods 0.000 description 2
• 238000010561 standard procedure Methods 0.000 description 2
• 235000000346 sugar Nutrition 0.000 description 2
• 208000024891 symptom Diseases 0.000 description 2
• 230000009885 systemic effect Effects 0.000 description 2
• 238000002560 therapeutic procedure Methods 0.000 description 2
• 231100000419 toxicity Toxicity 0.000 description 2
• 230000001988 toxicity Effects 0.000 description 2
• 238000011830 transgenic mouse model Methods 0.000 description 2
• 230000032258 transport Effects 0.000 description 2
• 150000003628 tricarboxylic acids Chemical class 0.000 description 2
• 241000701161 unidentified adenovirus Species 0.000 description 2
• 241001515965 unidentified phage Species 0.000 description 2
• 230000035899 viability Effects 0.000 description 2
• 230000004580 weight loss Effects 0.000 description 2
• 238000001262 western blot Methods 0.000 description 2
• DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
• ASWBNKHCZGQVJV-UHFFFAOYSA-N (3-hexadecanoyloxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)COP([O-])(=O)OCC[N+](C)(C)C ASWBNKHCZGQVJV-UHFFFAOYSA-N 0.000 description 1
• IBKGTULCXOYHFE-SEQYDFDVSA-N (4s)-4-amino-5-[[2-[[(2s)-1-[[(2s)-1-[[(2s)-1-[[(2s)-1-[(2s)-2-[[(1s)-1-carboxy-2-methylpropyl]carbamoyl]pyrrolidin-1-yl]-3-(4h-imidazol-4-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-methyl-1-o Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](N)CCC(O)=O)C(C)C)C(C)C)CC1N=CN=C1 IBKGTULCXOYHFE-SEQYDFDVSA-N 0.000 description 1
• 101710122378 10 kDa heat shock protein, mitochondrial Proteins 0.000 description 1
• QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
• UAIUNKRWKOVEES-UHFFFAOYSA-N 3,3',5,5'-tetramethylbenzidine Chemical compound CC1=C(N)C(C)=CC(C=2C=C(C)C(N)=C(C)C=2)=C1 UAIUNKRWKOVEES-UHFFFAOYSA-N 0.000 description 1
• 108010019608 3-Oxoacyl-(Acyl-Carrier-Protein) Synthase Proteins 0.000 description 1
• 108010055468 3-oxoacyl-(acyl-carrier-protein) reductase Proteins 0.000 description 1
• 102000000157 3-oxoacyl-(acyl-carrier-protein) reductase Human genes 0.000 description 1
• OSJPPGNTCRNQQC-UWTATZPHSA-N 3-phospho-D-glyceric acid Chemical compound OC(=O)[C@H](O)COP(O)(O)=O OSJPPGNTCRNQQC-UWTATZPHSA-N 0.000 description 1
• 102100023912 40S ribosomal protein S12 Human genes 0.000 description 1
• 102100033051 40S ribosomal protein S19 Human genes 0.000 description 1
• 102100024088 40S ribosomal protein S7 Human genes 0.000 description 1
• 102100037663 40S ribosomal protein S8 Human genes 0.000 description 1
• 101710135912 50S ribosomal protein L28 Proteins 0.000 description 1
• 102100021546 60S ribosomal protein L10 Human genes 0.000 description 1
• 102100024406 60S ribosomal protein L15 Human genes 0.000 description 1
• 102100021206 60S ribosomal protein L19 Human genes 0.000 description 1
• 101710187808 60S ribosomal protein L19 Proteins 0.000 description 1
• 102100037965 60S ribosomal protein L21 Human genes 0.000 description 1
• 102100037685 60S ribosomal protein L22 Human genes 0.000 description 1
• 101710187788 60S ribosomal protein L22 Proteins 0.000 description 1
• 102100021308 60S ribosomal protein L23 Human genes 0.000 description 1
• 102100035322 60S ribosomal protein L24 Human genes 0.000 description 1
• 102100038237 60S ribosomal protein L30 Human genes 0.000 description 1
• 102100026926 60S ribosomal protein L4 Human genes 0.000 description 1
• 108091006112 ATPases Proteins 0.000 description 1
• 208000032484 Accidental exposure to product Diseases 0.000 description 1
• 108010092060 Acetate kinase Proteins 0.000 description 1
• 108010002945 Acetoin dehydrogenase Proteins 0.000 description 1
• 102000057290 Adenosine Triphosphatases Human genes 0.000 description 1
• 241000193798 Aerococcus Species 0.000 description 1
• 239000005995 Aluminium silicate Substances 0.000 description 1
• 208000024827 Alzheimer disease Diseases 0.000 description 1
• 241000370685 Arge Species 0.000 description 1
• DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
• 201000001320 Atherosclerosis Diseases 0.000 description 1
• 208000023275 Autoimmune disease Diseases 0.000 description 1
• 208000036170 B-Cell Marginal Zone Lymphoma Diseases 0.000 description 1
• 102100022005 B-lymphocyte antigen CD20 Human genes 0.000 description 1
• 101100069823 Bacillus subtilis (strain 168) gutA gene Proteins 0.000 description 1
• 101100455969 Bacillus subtilis (strain 168) mdxK gene Proteins 0.000 description 1
• 108700003860 Bacterial Genes Proteins 0.000 description 1
• 208000035143 Bacterial infection Diseases 0.000 description 1
• 102100026189 Beta-galactosidase Human genes 0.000 description 1
• 241000186014 Bifidobacterium angulatum Species 0.000 description 1
• 241000186013 Bifidobacterium asteroides Species 0.000 description 1
• 241001312348 Bifidobacterium boum Species 0.000 description 1
• 241001312342 Bifidobacterium gallinarum Species 0.000 description 1
• 241000186156 Bifidobacterium indicum Species 0.000 description 1
• 241000186147 Bifidobacterium longum subsp. suis Species 0.000 description 1
• 241000186153 Bifidobacterium magnum Species 0.000 description 1
• 241001312344 Bifidobacterium merycicum Species 0.000 description 1
• 241001134772 Bifidobacterium pseudocatenulatum Species 0.000 description 1
• 241000186148 Bifidobacterium pseudolongum Species 0.000 description 1
• 241001312954 Bifidobacterium pullorum Species 0.000 description 1
• 241001312356 Bifidobacterium ruminantium Species 0.000 description 1
• 241001311520 Bifidobacterium saeculare Species 0.000 description 1
• 241001302264 Bifidobacterium subtile Species 0.000 description 1
• 241001034431 Bifidobacterium thermacidophilum Species 0.000 description 1
• 241001468229 Bifidobacterium thermophilum Species 0.000 description 1
• 239000002028 Biomass Substances 0.000 description 1
• 108010029692 Bisphosphoglycerate mutase Proteins 0.000 description 1
• 208000010392 Bone Fractures Diseases 0.000 description 1
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
• 102100032367 C-C motif chemokine 5 Human genes 0.000 description 1
• 102100024217 CAMPATH-1 antigen Human genes 0.000 description 1
• 101150104494 CAV1 gene Proteins 0.000 description 1
• ZXUDAQAUQSBITI-UHFFFAOYSA-N CC(N)=C(N)C(O)=O Chemical compound CC(N)=C(N)C(O)=O ZXUDAQAUQSBITI-UHFFFAOYSA-N 0.000 description 1
• 108700012434 CCL3 Proteins 0.000 description 1
• 102100027207 CD27 antigen Human genes 0.000 description 1
• 101150013553 CD40 gene Proteins 0.000 description 1
• 108010065524 CD52 Antigen Proteins 0.000 description 1
• 208000006339 Caliciviridae Infections Diseases 0.000 description 1
• 241000282421 Canidae Species 0.000 description 1
• 101800001318 Capsid protein VP4 Proteins 0.000 description 1
• 239000004215 Carbon black (E152) Substances 0.000 description 1
• 208000024172 Cardiovascular disease Diseases 0.000 description 1
• 102100025597 Caspase-4 Human genes 0.000 description 1
• 101710090338 Caspase-4 Proteins 0.000 description 1
• 101150047856 Cav2 gene Proteins 0.000 description 1
• 241000282693 Cercopithecidae Species 0.000 description 1
• 241000282994 Cervidae Species 0.000 description 1
• 108010059013 Chaperonin 10 Proteins 0.000 description 1
• 102000000013 Chemokine CCL3 Human genes 0.000 description 1
• 108010055166 Chemokine CCL5 Proteins 0.000 description 1
• VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
• 108010005939 Ciliary Neurotrophic Factor Proteins 0.000 description 1
• 102100031614 Ciliary neurotrophic factor Human genes 0.000 description 1
• 101100423897 Clostridium perfringens (strain 13 / Type A) glnS gene Proteins 0.000 description 1
• 101100039285 Clostridium perfringens (strain 13 / Type A) rpsM gene Proteins 0.000 description 1
• 108700010070 Codon Usage Proteins 0.000 description 1
• 208000015943 Coeliac disease Diseases 0.000 description 1
• 208000003322 Coinfection Diseases 0.000 description 1
• 206010009944 Colon cancer Diseases 0.000 description 1
• 108010071942 Colony-Stimulating Factors Proteins 0.000 description 1
• 208000035473 Communicable disease Diseases 0.000 description 1
• 108091035707 Consensus sequence Proteins 0.000 description 1
• 241000711573 Coronaviridae Species 0.000 description 1
• 241000186216 Corynebacterium Species 0.000 description 1
• 206010011224 Cough Diseases 0.000 description 1
• 201000003883 Cystic fibrosis Diseases 0.000 description 1
• 108010071840 Cytosol nonspecific dipeptidase Proteins 0.000 description 1
• 102100039498 Cytotoxic T-lymphocyte protein 4 Human genes 0.000 description 1
• 101710112752 Cytotoxin Proteins 0.000 description 1
• GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 1
• FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
• FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
• 102000053602 DNA Human genes 0.000 description 1
• 101710082494 DNA protection during starvation protein Proteins 0.000 description 1
• 102000052510 DNA-Binding Proteins Human genes 0.000 description 1
• 230000004568 DNA-binding Effects 0.000 description 1
• 101710096438 DNA-binding protein Proteins 0.000 description 1
• 101710195723 DNA-binding protein HU Proteins 0.000 description 1
• 101710088194 Dehydrogenase Proteins 0.000 description 1
• 239000004375 Dextrin Substances 0.000 description 1
• 229920001353 Dextrin Polymers 0.000 description 1
• 101100038183 Dictyostelium discoideum polr2a gene Proteins 0.000 description 1
• 101100306019 Dictyostelium discoideum polr2b gene Proteins 0.000 description 1
• 101100317179 Dictyostelium discoideum vps26 gene Proteins 0.000 description 1
• 208000000655 Distemper Diseases 0.000 description 1
• 102100027094 Echinoderm microtubule-associated protein-like 1 Human genes 0.000 description 1
• 241000196324 Embryophyta Species 0.000 description 1
• 101100407639 Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) prtB gene Proteins 0.000 description 1
• 108090000860 Endopeptidase Clp Proteins 0.000 description 1
• 241001345337 Enterococcus faecium PC4.1 Species 0.000 description 1
• 101710146739 Enterotoxin Proteins 0.000 description 1
• 102100023688 Eotaxin Human genes 0.000 description 1
• 101710139422 Eotaxin Proteins 0.000 description 1
• 108030004509 Erythrose-4-phosphate dehydrogenases Proteins 0.000 description 1
• 101100059891 Escherichia coli (strain K12) chbF gene Proteins 0.000 description 1
• 101100134102 Escherichia coli (strain K12) glnL gene Proteins 0.000 description 1
• LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
• 206010061850 Extranodal marginal zone B-cell lymphoma (MALT type) Diseases 0.000 description 1
• 108010020195 FLAG peptide Proteins 0.000 description 1
• XZWYTXMRWQJBGX-VXBMVYAYSA-N FLAG peptide Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(O)=O)CC1=CC=C(O)C=C1 XZWYTXMRWQJBGX-VXBMVYAYSA-N 0.000 description 1
• 208000004729 Feline Leukemia Diseases 0.000 description 1
• 241000714201 Feline calicivirus Species 0.000 description 1
• 241000714165 Feline leukemia virus Species 0.000 description 1
• 241000282324 Felis Species 0.000 description 1
• 208000004262 Food Hypersensitivity Diseases 0.000 description 1
• 206010017076 Fracture Diseases 0.000 description 1
• 229930091371 Fructose Natural products 0.000 description 1
• RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
• 239000005715 Fructose Substances 0.000 description 1
• 102000001390 Fructose-Bisphosphate Aldolase Human genes 0.000 description 1
• 101150039774 GAPA1 gene Proteins 0.000 description 1
• 208000007882 Gastritis Diseases 0.000 description 1
• 208000018522 Gastrointestinal disease Diseases 0.000 description 1
• 108700007698 Genetic Terminator Regions Proteins 0.000 description 1
• 208000031448 Genomic Instability Diseases 0.000 description 1
• 241000282818 Giraffidae Species 0.000 description 1
• 102400000326 Glucagon-like peptide 2 Human genes 0.000 description 1
• 101800000221 Glucagon-like peptide 2 Proteins 0.000 description 1
• 102100031132 Glucose-6-phosphate isomerase Human genes 0.000 description 1
• 108010070600 Glucose-6-phosphate isomerase Proteins 0.000 description 1
• 108010015514 Glutamate-tRNA ligase Proteins 0.000 description 1
• 102100024977 Glutamine-tRNA ligase Human genes 0.000 description 1
• 108010058940 Glutamyl Aminopeptidase Proteins 0.000 description 1
• 102000006485 Glutamyl Aminopeptidase Human genes 0.000 description 1
• 108010068370 Glutens Proteins 0.000 description 1
• 239000004471 Glycine Substances 0.000 description 1
• 238000003794 Gram staining Methods 0.000 description 1
• 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 1
• 208000031220 Hemophilia Diseases 0.000 description 1
• 208000009292 Hemophilia A Diseases 0.000 description 1
• 108090000100 Hepatocyte Growth Factor Proteins 0.000 description 1
• 102100021866 Hepatocyte growth factor Human genes 0.000 description 1
• 241000238631 Hexapoda Species 0.000 description 1
• 102000005548 Hexokinase Human genes 0.000 description 1
• 108700040460 Hexokinases Proteins 0.000 description 1
• 241001272567 Hominoidea Species 0.000 description 1
• 101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 description 1
• 101000914511 Homo sapiens CD27 antigen Proteins 0.000 description 1
• 101000889276 Homo sapiens Cytotoxic T-lymphocyte protein 4 Proteins 0.000 description 1
• 101001057941 Homo sapiens Echinoderm microtubule-associated protein-like 1 Proteins 0.000 description 1
• 101001019455 Homo sapiens ICOS ligand Proteins 0.000 description 1
• 101000998139 Homo sapiens Interleukin-32 Proteins 0.000 description 1
• 101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 description 1
• 101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 description 1
• 101000611023 Homo sapiens Tumor necrosis factor receptor superfamily member 6 Proteins 0.000 description 1
• 101000851376 Homo sapiens Tumor necrosis factor receptor superfamily member 8 Proteins 0.000 description 1
• VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
• 101000963974 Hydrophis stokesii Alpha-elapitoxin-Ast2b Proteins 0.000 description 1
• 102100034980 ICOS ligand Human genes 0.000 description 1
• 208000022559 Inflammatory bowel disease Diseases 0.000 description 1
• 102000004877 Insulin Human genes 0.000 description 1
• 108090001061 Insulin Proteins 0.000 description 1
• 108010041012 Integrin alpha4 Proteins 0.000 description 1
• 102000000589 Interleukin-1 Human genes 0.000 description 1
• 108010002352 Interleukin-1 Proteins 0.000 description 1
• 102000004560 Interleukin-12 Receptors Human genes 0.000 description 1
• 108010017515 Interleukin-12 Receptors Proteins 0.000 description 1
• 108090000176 Interleukin-13 Proteins 0.000 description 1
• 102000003816 Interleukin-13 Human genes 0.000 description 1
• 108090000172 Interleukin-15 Proteins 0.000 description 1
• 102000003812 Interleukin-15 Human genes 0.000 description 1
• 101800003050 Interleukin-16 Proteins 0.000 description 1
• 102000049772 Interleukin-16 Human genes 0.000 description 1
• 108010002350 Interleukin-2 Proteins 0.000 description 1
• 102100030703 Interleukin-22 Human genes 0.000 description 1
• 101710195550 Interleukin-23 receptor Proteins 0.000 description 1
• 108090000978 Interleukin-4 Proteins 0.000 description 1
• 108010002616 Interleukin-5 Proteins 0.000 description 1
• 102100037792 Interleukin-6 receptor subunit alpha Human genes 0.000 description 1
• 108010002586 Interleukin-7 Proteins 0.000 description 1
• 108010002335 Interleukin-9 Proteins 0.000 description 1
• 102000015696 Interleukins Human genes 0.000 description 1
• 108010063738 Interleukins Proteins 0.000 description 1
• 108091023242 Internal transcribed spacer Proteins 0.000 description 1
• 241001580017 Jana Species 0.000 description 1
• YQEZLKZALYSWHR-UHFFFAOYSA-N Ketamine Chemical compound C=1C=CC=C(Cl)C=1C1(NC)CCCCC1=O YQEZLKZALYSWHR-UHFFFAOYSA-N 0.000 description 1
• DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
• 101100463438 Lactobacillus delbrueckii subsp. lactis pepV gene Proteins 0.000 description 1
• 241000194040 Lactococcus garvieae Species 0.000 description 1
• 241000194039 Lactococcus piscium Species 0.000 description 1
• 241000194038 Lactococcus plantarum Species 0.000 description 1
• 241000194037 Lactococcus raffinolactis Species 0.000 description 1
• 101100433987 Latilactobacillus sakei subsp. sakei (strain 23K) ackA1 gene Proteins 0.000 description 1
• 101100529965 Leptospira borgpetersenii serovar Hardjo-bovis (strain L550) rpsK2 gene Proteins 0.000 description 1
• 101100088535 Leptospira interrogans serogroup Icterohaemorrhagiae serovar Lai (strain 56601) rplP gene Proteins 0.000 description 1
• 241000192132 Leuconostoc Species 0.000 description 1
• 239000000232 Lipid Bilayer Substances 0.000 description 1
• 208000019693 Lung disease Diseases 0.000 description 1
• 239000004472 Lysine Substances 0.000 description 1
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
• 201000003791 MALT lymphoma Diseases 0.000 description 1
• 102000034655 MIF Human genes 0.000 description 1
• 108060004872 MIF Proteins 0.000 description 1
• 108010061593 Member 14 Tumor Necrosis Factor Receptors Proteins 0.000 description 1
• 101100038261 Methanococcus vannielii (strain ATCC 35089 / DSM 1224 / JCM 13029 / OCM 148 / SB) rpo2C gene Proteins 0.000 description 1
• 101100303649 Methanopyrus kandleri (strain AV19 / DSM 6324 / JCM 9639 / NBRC 100938) rpl24 gene Proteins 0.000 description 1
• 101100200099 Methanopyrus kandleri (strain AV19 / DSM 6324 / JCM 9639 / NBRC 100938) rps13 gene Proteins 0.000 description 1
• 206010028116 Mucosal inflammation Diseases 0.000 description 1
• 201000010927 Mucositis Diseases 0.000 description 1
• 241000699660 Mus musculus Species 0.000 description 1
• 101000653787 Mus musculus Protein S100-A11 Proteins 0.000 description 1
• 101100046526 Mus musculus Tnf gene Proteins 0.000 description 1
• 206010028289 Muscle atrophy Diseases 0.000 description 1
• 101000964025 Naja naja Long neurotoxin 3 Proteins 0.000 description 1
• 241000588652 Neisseria gonorrhoeae Species 0.000 description 1
• 108010025020 Nerve Growth Factor Proteins 0.000 description 1
• 102000007072 Nerve Growth Factors Human genes 0.000 description 1
• 208000012902 Nervous system disease Diseases 0.000 description 1
• 208000025966 Neurological disease Diseases 0.000 description 1
• 208000008589 Obesity Diseases 0.000 description 1
• 241000202223 Oenococcus Species 0.000 description 1
• 206010030216 Oesophagitis Diseases 0.000 description 1
• 241000282579 Pan Species 0.000 description 1
• 241000282320 Panthera leo Species 0.000 description 1
• 241000282376 Panthera tigris Species 0.000 description 1
• 208000018737 Parkinson disease Diseases 0.000 description 1
• 241001494479 Pecora Species 0.000 description 1
• 241000192001 Pediococcus Species 0.000 description 1
• 208000008469 Peptic Ulcer Diseases 0.000 description 1
• 108091005804 Peptidases Proteins 0.000 description 1
• 108010068204 Peptide Elongation Factors Proteins 0.000 description 1
• 102000002508 Peptide Elongation Factors Human genes 0.000 description 1
• 244000304393 Phlox paniculata Species 0.000 description 1
• 102000001105 Phosphofructokinases Human genes 0.000 description 1
• 108010069341 Phosphofructokinases Proteins 0.000 description 1
• 102000011755 Phosphoglycerate Kinase Human genes 0.000 description 1
• 102000011025 Phosphoglycerate Mutase Human genes 0.000 description 1
• 241000282405 Pongo abelii Species 0.000 description 1
• 206010036774 Proctitis Diseases 0.000 description 1
• 108010049404 Prokaryotic Initiation Factor-3 Proteins 0.000 description 1
• 102100026126 Proline-tRNA ligase Human genes 0.000 description 1
• 239000004365 Protease Substances 0.000 description 1
• 108010001267 Protein Subunits Proteins 0.000 description 1
• 102000002067 Protein Subunits Human genes 0.000 description 1
• 101710130181 Protochlorophyllide reductase A, chloroplastic Proteins 0.000 description 1
• 241000125945 Protoparvovirus Species 0.000 description 1
• 101100282114 Pseudomonas aeruginosa (strain UCBPP-PA14) gap2 gene Proteins 0.000 description 1
• 201000004681 Psoriasis Diseases 0.000 description 1
• 102000013009 Pyruvate Kinase Human genes 0.000 description 1
• 108020005115 Pyruvate Kinase Proteins 0.000 description 1
• 238000011529 RT qPCR Methods 0.000 description 1
• 108020004511 Recombinant DNA Proteins 0.000 description 1
• 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
• 206010051497 Rhinotracheitis Diseases 0.000 description 1
• 108090000986 Ribosomal protein L10 Proteins 0.000 description 1
• 102000004387 Ribosomal protein L14 Human genes 0.000 description 1
• 108090000985 Ribosomal protein L14 Proteins 0.000 description 1
• 108090000983 Ribosomal protein L15 Proteins 0.000 description 1
• 102000003926 Ribosomal protein L18 Human genes 0.000 description 1
• 108090000343 Ribosomal protein L18 Proteins 0.000 description 1
• 102000004208 Ribosomal protein L2 Human genes 0.000 description 1
• 108090000775 Ribosomal protein L2 Proteins 0.000 description 1
• 108050001924 Ribosomal protein L23 Proteins 0.000 description 1
• 102000008837 Ribosomal protein L7/L12 Human genes 0.000 description 1
• 108050000743 Ribosomal protein L7/L12 Proteins 0.000 description 1
• 102000004394 Ribosomal protein S10 Human genes 0.000 description 1
• 108090000928 Ribosomal protein S10 Proteins 0.000 description 1
• 102000010983 Ribosomal protein S13 Human genes 0.000 description 1
• 108050001197 Ribosomal protein S13 Proteins 0.000 description 1
• 102000004339 Ribosomal protein S2 Human genes 0.000 description 1
• 108090000904 Ribosomal protein S2 Proteins 0.000 description 1
• 241000283984 Rodentia Species 0.000 description 1
• 101150102982 RpS10 gene Proteins 0.000 description 1
• 101150034081 Rpl18 gene Proteins 0.000 description 1
• IQFWYNFDWRYSRA-OEQWSMLSSA-N S-(5-deoxy-beta-D-ribos-5-yl)-L-homocysteine Chemical compound OC(=O)[C@@H](N)CCSC[C@H]1O[C@@H](O)[C@H](O)[C@@H]1O IQFWYNFDWRYSRA-OEQWSMLSSA-N 0.000 description 1
• CGNLCCVKSWNSDG-UHFFFAOYSA-N SYBR Green I Chemical compound CN(C)CCCN(CCC)C1=CC(C=C2N(C3=CC=CC=C3S2)C)=C2C=CC=CC2=[N+]1C1=CC=CC=C1 CGNLCCVKSWNSDG-UHFFFAOYSA-N 0.000 description 1
• PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
• 241000204117 Sporolactobacillus Species 0.000 description 1
• 208000005718 Stomach Neoplasms Diseases 0.000 description 1
• 241000194017 Streptococcus Species 0.000 description 1
• 241000194026 Streptococcus gordonii Species 0.000 description 1
• 101100292254 Streptococcus mutans serotype c (strain ATCC 700610 / UA159) msmK gene Proteins 0.000 description 1
• 241000194020 Streptococcus thermophilus Species 0.000 description 1
• 238000000692 Student's t-test Methods 0.000 description 1
• 241000282887 Suidae Species 0.000 description 1
• 102000019197 Superoxide Dismutase Human genes 0.000 description 1
• 108010012715 Superoxide dismutase Proteins 0.000 description 1
• 206010042602 Supraventricular extrasystoles Diseases 0.000 description 1
• 101100147268 Symbiobacterium thermophilum (strain T / IAM 14863) rpsD1 gene Proteins 0.000 description 1
• 108700005078 Synthetic Genes Proteins 0.000 description 1
• 102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 description 1
• 210000001744 T-lymphocyte Anatomy 0.000 description 1
• 102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 description 1
• 108700026226 TATA Box Proteins 0.000 description 1
• 241000500334 Tetragenococcus Species 0.000 description 1
• 101001099217 Thermotoga maritima (strain ATCC 43589 / DSM 3109 / JCM 10099 / NBRC 100826 / MSB8) Triosephosphate isomerase Proteins 0.000 description 1
• 102000003978 Tissue Plasminogen Activator Human genes 0.000 description 1
• 108090000373 Tissue Plasminogen Activator Proteins 0.000 description 1
• 102000002689 Toll-like receptor Human genes 0.000 description 1
• 108020000411 Toll-like receptor Proteins 0.000 description 1
• 206010044302 Tracheitis Diseases 0.000 description 1
• 108700009124 Transcription Initiation Site Proteins 0.000 description 1
• 102000009618 Transforming Growth Factors Human genes 0.000 description 1
• 108010009583 Transforming Growth Factors Proteins 0.000 description 1
• 206010052779 Transplant rejections Diseases 0.000 description 1
• 102000005924 Triose-Phosphate Isomerase Human genes 0.000 description 1
• 108700015934 Triose-phosphate isomerases Proteins 0.000 description 1
• 108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 description 1
• 102100036922 Tumor necrosis factor ligand superfamily member 13B Human genes 0.000 description 1
• 101710181056 Tumor necrosis factor ligand superfamily member 13B Proteins 0.000 description 1
• 102100028785 Tumor necrosis factor receptor superfamily member 14 Human genes 0.000 description 1
• 102100022153 Tumor necrosis factor receptor superfamily member 4 Human genes 0.000 description 1
• 101710165473 Tumor necrosis factor receptor superfamily member 4 Proteins 0.000 description 1
• 102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 description 1
• 102100040403 Tumor necrosis factor receptor superfamily member 6 Human genes 0.000 description 1
• 102100036857 Tumor necrosis factor receptor superfamily member 8 Human genes 0.000 description 1
• 108010057446 UDP-galactopyranose mutase Proteins 0.000 description 1
• 241000207194 Vagococcus Species 0.000 description 1
• 208000036142 Viral infection Diseases 0.000 description 1
• 208000027418 Wounds and injury Diseases 0.000 description 1
• 108030004686 Xaa-Pro aminopeptidases Proteins 0.000 description 1
• 238000002835 absorbance Methods 0.000 description 1
• 238000010521 absorption reaction Methods 0.000 description 1
• 101150070497 accC gene Proteins 0.000 description 1
• 231100000818 accidental exposure Toxicity 0.000 description 1
• 101150006213 ackA gene Proteins 0.000 description 1
• 101150016772 acoA gene Proteins 0.000 description 1
• 230000003213 activating effect Effects 0.000 description 1
• 239000013543 active substance Substances 0.000 description 1
• 230000001154 acute effect Effects 0.000 description 1
• 239000000654 additive Substances 0.000 description 1
• 238000009098 adjuvant therapy Methods 0.000 description 1
• 230000001270 agonistic effect Effects 0.000 description 1
• 239000003513 alkali Substances 0.000 description 1
• 208000026935 allergic disease Diseases 0.000 description 1
• 230000000735 allogeneic effect Effects 0.000 description 1
• XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
• 229910052782 aluminium Inorganic materials 0.000 description 1
• WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
• 235000012211 aluminium silicate Nutrition 0.000 description 1
• 230000003698 anagen phase Effects 0.000 description 1
• 238000010171 animal model Methods 0.000 description 1
• 150000001450 anions Chemical class 0.000 description 1
• 239000005557 antagonist Substances 0.000 description 1
• 230000001772 anti-angiogenic effect Effects 0.000 description 1
• 230000001130 anti-lysozyme effect Effects 0.000 description 1
• 239000007900 aqueous suspension Substances 0.000 description 1
• 229960001230 asparagine Drugs 0.000 description 1
• 235000009582 asparagine Nutrition 0.000 description 1
• 208000006673 asthma Diseases 0.000 description 1
• 101150088806 atpA gene Proteins 0.000 description 1
• 101150026213 atpB gene Proteins 0.000 description 1
• 101150035600 atpD gene Proteins 0.000 description 1
• 101150099875 atpE gene Proteins 0.000 description 1
• 101150048329 atpH gene Proteins 0.000 description 1
• 238000013475 authorization Methods 0.000 description 1
• 210000003719 b-lymphocyte Anatomy 0.000 description 1
• 208000022362 bacterial infectious disease Diseases 0.000 description 1
• 239000011324 bead Substances 0.000 description 1
• 230000009286 beneficial effect Effects 0.000 description 1
• 230000001588 bifunctional effect Effects 0.000 description 1
• 210000000941 bile Anatomy 0.000 description 1
• 239000000227 bioadhesive Substances 0.000 description 1
• 239000000090 biomarker Substances 0.000 description 1
• 101150037483 bkdA gene Proteins 0.000 description 1
• 210000004369 blood Anatomy 0.000 description 1
• 239000008280 blood Substances 0.000 description 1
• 229940098773 bovine serum albumin Drugs 0.000 description 1
• 210000004556 brain Anatomy 0.000 description 1
• 210000004899 c-terminal region Anatomy 0.000 description 1
• 238000010804 cDNA synthesis Methods 0.000 description 1
• 238000010805 cDNA synthesis kit Methods 0.000 description 1
• 229910052793 cadmium Inorganic materials 0.000 description 1
• BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
• 208000014058 canine distemper Diseases 0.000 description 1
• 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
• 239000000969 carrier Substances 0.000 description 1
• 239000012876 carrier material Substances 0.000 description 1
• 238000004113 cell culture Methods 0.000 description 1
• 230000032823 cell division Effects 0.000 description 1
• 230000003915 cell function Effects 0.000 description 1
• 230000001413 cellular effect Effects 0.000 description 1
• 239000001913 cellulose Substances 0.000 description 1
• 229920002678 cellulose Polymers 0.000 description 1
• 230000008859 change Effects 0.000 description 1
• 238000012512 characterization method Methods 0.000 description 1
• 238000006243 chemical reaction Methods 0.000 description 1
• 239000003795 chemical substances by application Substances 0.000 description 1
• 229960005091 chloramphenicol Drugs 0.000 description 1
• WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
• 101150074451 clpP gene Proteins 0.000 description 1
• 101150043719 clpP1 gene Proteins 0.000 description 1
• 101150102296 clpP2 gene Proteins 0.000 description 1
• 230000015271 coagulation Effects 0.000 description 1
• 238000005345 coagulation Methods 0.000 description 1
• 230000000112 colonic effect Effects 0.000 description 1
• 208000029742 colonic neoplasm Diseases 0.000 description 1
• 230000000295 complement effect Effects 0.000 description 1
• 239000002299 complementary DNA Substances 0.000 description 1
• 238000012790 confirmation Methods 0.000 description 1
• 239000000039 congener Substances 0.000 description 1
• 238000007796 conventional method Methods 0.000 description 1
• 238000010411 cooking Methods 0.000 description 1
• 239000006071 cream Substances 0.000 description 1
• 238000003235 crystal violet staining Methods 0.000 description 1
• 230000016396 cytokine production Effects 0.000 description 1
• 108010057085 cytokine receptors Proteins 0.000 description 1
• 102000003675 cytokine receptors Human genes 0.000 description 1
• 210000000805 cytoplasm Anatomy 0.000 description 1
• 230000001086 cytosolic effect Effects 0.000 description 1
• 231100000599 cytotoxic agent Toxicity 0.000 description 1
• 239000002619 cytotoxin Substances 0.000 description 1
• 235000013365 dairy product Nutrition 0.000 description 1
• 230000002950 deficient Effects 0.000 description 1
• 230000003412 degenerative effect Effects 0.000 description 1
• 239000007857 degradation product Substances 0.000 description 1
• 230000003111 delayed effect Effects 0.000 description 1
• 238000001514 detection method Methods 0.000 description 1
• 230000001627 detrimental effect Effects 0.000 description 1
• 235000019425 dextrin Nutrition 0.000 description 1
• 206010012601 diabetes mellitus Diseases 0.000 description 1
• 238000003745 diagnosis Methods 0.000 description 1
• 230000001079 digestive effect Effects 0.000 description 1
• 231100000676 disease causative agent Toxicity 0.000 description 1
• PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 1
• BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
• 210000004921 distal colon Anatomy 0.000 description 1
• 239000012153 distilled water Substances 0.000 description 1
• 238000009826 distribution Methods 0.000 description 1
• 229940079593 drug Drugs 0.000 description 1
• 239000003937 drug carrier Substances 0.000 description 1
• 208000000718 duodenal ulcer Diseases 0.000 description 1
• 201000006549 dyspepsia Diseases 0.000 description 1
• 230000000546 effect on cell death Effects 0.000 description 1
• 239000000839 emulsion Substances 0.000 description 1
• 239000002158 endotoxin Substances 0.000 description 1
• 229940079360 enema for constipation Drugs 0.000 description 1
• 239000003623 enhancer Substances 0.000 description 1
• 101150107963 eno gene Proteins 0.000 description 1
• 239000000147 enterotoxin Substances 0.000 description 1
• 231100000655 enterotoxin Toxicity 0.000 description 1
• YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
• 208000006881 esophagitis Diseases 0.000 description 1
• 210000003238 esophagus Anatomy 0.000 description 1
• 239000002095 exotoxin Substances 0.000 description 1
• 231100000776 exotoxin Toxicity 0.000 description 1
• 239000013613 expression plasmid Substances 0.000 description 1
• 101150015067 fabB gene Proteins 0.000 description 1
• 101150026389 fabF gene Proteins 0.000 description 1
• 101150090981 fabG gene Proteins 0.000 description 1
• 101150031187 fba gene Proteins 0.000 description 1
• 101150108901 fbaA gene Proteins 0.000 description 1
• 208000005098 feline infectious peritonitis Diseases 0.000 description 1
• 238000000855 fermentation Methods 0.000 description 1
• 230000004151 fermentation Effects 0.000 description 1
• 238000001943 fluorescence-activated cell sorting Methods 0.000 description 1
• 235000020932 food allergy Nutrition 0.000 description 1
• 239000003205 fragrance Substances 0.000 description 1
• 231100000221 frame shift mutation induction Toxicity 0.000 description 1
• 230000037433 frameshift Effects 0.000 description 1
• 238000004108 freeze drying Methods 0.000 description 1
• 101150052059 frvX gene Proteins 0.000 description 1
• 101150101609 ftsA gene Proteins 0.000 description 1
• 101150091570 gapA gene Proteins 0.000 description 1
• 206010017758 gastric cancer Diseases 0.000 description 1
• 230000002496 gastric effect Effects 0.000 description 1
• 208000021302 gastroesophageal reflux disease Diseases 0.000 description 1
• 238000003304 gavage Methods 0.000 description 1
• 235000021474 generally recognized As safe (food) Nutrition 0.000 description 1
• 235000021472 generally recognized as safe Nutrition 0.000 description 1
• 235000021473 generally recognized as safe (food ingredients) Nutrition 0.000 description 1
• 238000010353 genetic engineering Methods 0.000 description 1
• 239000011521 glass Substances 0.000 description 1
• 101150035089 glnR gene Proteins 0.000 description 1
• 101150024902 glnS gene Proteins 0.000 description 1
• 101150103988 gltX gene Proteins 0.000 description 1
• TWSALRJGPBVBQU-PKQQPRCHSA-N glucagon-like peptide 2 Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O)[C@@H](C)CC)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)CC)C1=CC=CC=C1 TWSALRJGPBVBQU-PKQQPRCHSA-N 0.000 description 1
• 108020002326 glutamine synthetase Proteins 0.000 description 1
• 102000005396 glutamine synthetase Human genes 0.000 description 1
• 108010064177 glutamine synthetase I Proteins 0.000 description 1
• 108010051239 glutaminyl-tRNA synthetase Proteins 0.000 description 1
• 108010086632 glutamyl-glycyl-valyl-tyrosyl-valyl-histidyl-prolyl-valine Proteins 0.000 description 1
• 235000021312 gluten Nutrition 0.000 description 1
• 101150004480 greA gene Proteins 0.000 description 1
• 101150006844 groES gene Proteins 0.000 description 1
• 239000003102 growth factor Substances 0.000 description 1
• 230000035876 healing Effects 0.000 description 1
• 230000002008 hemorrhagic effect Effects 0.000 description 1
• 208000006454 hepatitis Diseases 0.000 description 1
• 231100000283 hepatitis Toxicity 0.000 description 1
• 238000012165 high-throughput sequencing Methods 0.000 description 1
• 238000000265 homogenisation Methods 0.000 description 1
• 229930195733 hydrocarbon Natural products 0.000 description 1
• 150000002430 hydrocarbons Chemical class 0.000 description 1
• 230000005934 immune activation Effects 0.000 description 1
• 230000028993 immune response Effects 0.000 description 1
• 210000000987 immune system Anatomy 0.000 description 1
• 230000003053 immunization Effects 0.000 description 1
• 238000002649 immunization Methods 0.000 description 1
• 230000016784 immunoglobulin production Effects 0.000 description 1
• 239000003018 immunosuppressive agent Substances 0.000 description 1
• 229940124589 immunosuppressive drug Drugs 0.000 description 1
• 230000001976 improved effect Effects 0.000 description 1
• 230000006872 improvement Effects 0.000 description 1
• 101150077178 infC gene Proteins 0.000 description 1
• 230000002458 infectious effect Effects 0.000 description 1
• 230000028709 inflammatory response Effects 0.000 description 1
• 229960000598 infliximab Drugs 0.000 description 1
• 239000004615 ingredient Substances 0.000 description 1
• 239000003112 inhibitor Substances 0.000 description 1
• 208000014674 injury Diseases 0.000 description 1
• 238000011081 inoculation Methods 0.000 description 1
• 229910052500 inorganic mineral Inorganic materials 0.000 description 1
• 229940125396 insulin Drugs 0.000 description 1
• 108010044426 integrins Proteins 0.000 description 1
• 102000006495 integrins Human genes 0.000 description 1
• 230000003993 interaction Effects 0.000 description 1
• 102000008616 interleukin-15 receptor activity proteins Human genes 0.000 description 1
• 108040002039 interleukin-15 receptor activity proteins Proteins 0.000 description 1
• 102000053460 interleukin-17 receptor activity proteins Human genes 0.000 description 1
• 108040001304 interleukin-17 receptor activity proteins Proteins 0.000 description 1
• 108040006849 interleukin-2 receptor activity proteins Proteins 0.000 description 1
• 108010074108 interleukin-21 Proteins 0.000 description 1
• 108040001844 interleukin-23 receptor activity proteins Proteins 0.000 description 1
• 108040006858 interleukin-6 receptor activity proteins Proteins 0.000 description 1
• 229940047122 interleukins Drugs 0.000 description 1
• 239000000543 intermediate Substances 0.000 description 1
• 210000002490 intestinal epithelial cell Anatomy 0.000 description 1
• 238000007912 intraperitoneal administration Methods 0.000 description 1
• 239000007928 intraperitoneal injection Substances 0.000 description 1
• 238000002955 isolation Methods 0.000 description 1
• NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
• 229960003299 ketamine Drugs 0.000 description 1
• 201000010901 lateral sclerosis Diseases 0.000 description 1
• 150000002632 lipids Chemical class 0.000 description 1
• 208000019423 liver disease Diseases 0.000 description 1
• 206010025135 lupus erythematosus Diseases 0.000 description 1
• 101150078797 luxS gene Proteins 0.000 description 1
• 239000008176 lyophilized powder Substances 0.000 description 1
• 239000006166 lysate Substances 0.000 description 1
• 239000012139 lysis buffer Substances 0.000 description 1
• 101150068528 mabA gene Proteins 0.000 description 1
• 229960003511 macrogol Drugs 0.000 description 1
• 235000019359 magnesium stearate Nutrition 0.000 description 1
• 101150003248 malK gene Proteins 0.000 description 1
• 238000007726 management method Methods 0.000 description 1
• 239000003550 marker Substances 0.000 description 1
• 238000000074 matrix-assisted laser desorption--ionisation tandem time-of-flight detection Methods 0.000 description 1
• 238000005259 measurement Methods 0.000 description 1
• 239000012528 membrane Substances 0.000 description 1
• 210000004379 membrane Anatomy 0.000 description 1
• 230000037353 metabolic pathway Effects 0.000 description 1
• 230000004060 metabolic process Effects 0.000 description 1
• 230000000813 microbial effect Effects 0.000 description 1
• 235000013336 milk Nutrition 0.000 description 1
• 239000008267 milk Substances 0.000 description 1
• 210000004080 milk Anatomy 0.000 description 1
• 230000003278 mimic effect Effects 0.000 description 1
• 239000011707 mineral Substances 0.000 description 1
• 208000024191 minimally invasive lung adenocarcinoma Diseases 0.000 description 1
• 239000003607 modifier Substances 0.000 description 1
• 238000010369 molecular cloning Methods 0.000 description 1
• 238000012544 monitoring process Methods 0.000 description 1
• 235000013923 monosodium glutamate Nutrition 0.000 description 1
• 208000005264 motor neuron disease Diseases 0.000 description 1
• 210000004877 mucosa Anatomy 0.000 description 1
• 230000020763 muscle atrophy Effects 0.000 description 1
• 201000000585 muscular atrophy Diseases 0.000 description 1
• 230000035772 mutation Effects 0.000 description 1
• 239000003900 neurotrophic factor Substances 0.000 description 1
• 230000011242 neutrophil chemotaxis Effects 0.000 description 1
• JPXMTWWFLBLUCD-UHFFFAOYSA-N nitro blue tetrazolium(2+) Chemical compound COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=C([N+]([O-])=O)C=C1 JPXMTWWFLBLUCD-UHFFFAOYSA-N 0.000 description 1
• 235000020824 obesity Nutrition 0.000 description 1
• 239000003921 oil Substances 0.000 description 1
• 235000019198 oils Nutrition 0.000 description 1
• 239000002674 ointment Substances 0.000 description 1
• 239000004006 olive oil Substances 0.000 description 1
• 235000008390 olive oil Nutrition 0.000 description 1
• 238000003305 oral gavage Methods 0.000 description 1
• 230000004792 oxidative damage Effects 0.000 description 1
• 238000004806 packaging method and process Methods 0.000 description 1
• 210000003134 paneth cell Anatomy 0.000 description 1
• 239000012188 paraffin wax Substances 0.000 description 1
• 230000003950 pathogenic mechanism Effects 0.000 description 1
• 230000037361 pathway Effects 0.000 description 1
• 101150084945 pdhA gene Proteins 0.000 description 1
• 239000008188 pellet Substances 0.000 description 1
• 230000004108 pentose phosphate pathway Effects 0.000 description 1
• 101150093025 pepA gene Proteins 0.000 description 1
• 101150074180 pepP gene Proteins 0.000 description 1
• 101150095786 pepPI gene Proteins 0.000 description 1
• 230000001175 peptic effect Effects 0.000 description 1
• 208000011906 peptic ulcer disease Diseases 0.000 description 1
• KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 1
• 230000000737 periodic effect Effects 0.000 description 1
• 238000001050 pharmacotherapy Methods 0.000 description 1
• 238000007747 plating Methods 0.000 description 1
• 229920001983 poloxamer Polymers 0.000 description 1
• 229920005862 polyol Polymers 0.000 description 1
• 150000003077 polyols Chemical class 0.000 description 1
• 230000002265 prevention Effects 0.000 description 1
• 208000037920 primary disease Diseases 0.000 description 1
• 239000006041 probiotic Substances 0.000 description 1
• 230000000529 probiotic effect Effects 0.000 description 1
• 235000018291 probiotics Nutrition 0.000 description 1
• 230000008569 process Effects 0.000 description 1
• 238000004393 prognosis Methods 0.000 description 1
• 230000002062 proliferating effect Effects 0.000 description 1
• 230000035755 proliferation Effects 0.000 description 1
• 230000001737 promoting effect Effects 0.000 description 1
• 230000000644 propagated effect Effects 0.000 description 1
• 238000011321 prophylaxis Methods 0.000 description 1
• 230000012846 protein folding Effects 0.000 description 1
• 101150104624 ptcB gene Proteins 0.000 description 1
• 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
• 230000005855 radiation Effects 0.000 description 1
• 238000001959 radiotherapy Methods 0.000 description 1
• 230000000306 recurrent effect Effects 0.000 description 1
• 239000012925 reference material Substances 0.000 description 1
• 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
• 230000008844 regulatory mechanism Effects 0.000 description 1
• 238000011160 research Methods 0.000 description 1
• 230000000717 retained effect Effects 0.000 description 1
• 206010039073 rheumatoid arthritis Diseases 0.000 description 1
• 108020004418 ribosomal RNA Proteins 0.000 description 1
• 108010025591 ribosomal protein L16 Proteins 0.000 description 1
• 108090000327 ribosomal protein L21 Proteins 0.000 description 1
• 108010025463 ribosomal protein L24 Proteins 0.000 description 1
• 108010025327 ribosomal protein L30 Proteins 0.000 description 1
• 108090000893 ribosomal protein L4 Proteins 0.000 description 1
• 102000004413 ribosomal protein S11 Human genes 0.000 description 1
• 108090000930 ribosomal protein S11 Proteins 0.000 description 1
• 108010092841 ribosomal protein S12 Proteins 0.000 description 1
• 108010093046 ribosomal protein S19 Proteins 0.000 description 1
• 108010033786 ribosomal protein S4 Proteins 0.000 description 1
• 102000004337 ribosomal protein S5 Human genes 0.000 description 1
• 108090000902 ribosomal protein S5 Proteins 0.000 description 1
• 108010033405 ribosomal protein S7 Proteins 0.000 description 1
• 108010033800 ribosomal protein S8 Proteins 0.000 description 1
• 101150091119 rpl18a gene Proteins 0.000 description 1
• 101150043079 rpl22 gene Proteins 0.000 description 1
• 101150028073 rplD gene Proteins 0.000 description 1
• 101150037704 rplJ gene Proteins 0.000 description 1
• 101150100282 rplK gene Proteins 0.000 description 1
• 101150118024 rplK1 gene Proteins 0.000 description 1
• 101150050931 rplL gene Proteins 0.000 description 1
• 101150117577 rplO gene Proteins 0.000 description 1
• 101150066158 rplR gene Proteins 0.000 description 1
• 101150070580 rplV gene Proteins 0.000 description 1
• 101150075881 rplX gene Proteins 0.000 description 1
• 101150047139 rpo1N gene Proteins 0.000 description 1
• 101150085857 rpo2 gene Proteins 0.000 description 1
• 101150037064 rpoA gene Proteins 0.000 description 1
• 101150090202 rpoB gene Proteins 0.000 description 1
• 101150087540 rpsD gene Proteins 0.000 description 1
• 101150114376 rpsD2 gene Proteins 0.000 description 1
• 101150094975 rpsH gene Proteins 0.000 description 1
• 101150103887 rpsJ gene Proteins 0.000 description 1
• 101150039612 rpsK gene Proteins 0.000 description 1
• 101150098466 rpsL gene Proteins 0.000 description 1
• 101150049069 rpsM gene Proteins 0.000 description 1
• 101150061587 rpsS gene Proteins 0.000 description 1
• CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
• 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
• 239000012723 sample buffer Substances 0.000 description 1
• 229930182490 saponin Natural products 0.000 description 1
• 150000007949 saponins Chemical class 0.000 description 1
• 238000007873 sieving Methods 0.000 description 1
• 230000019491 signal transduction Effects 0.000 description 1
• 239000000377 silicon dioxide Substances 0.000 description 1
• 229910000029 sodium carbonate Inorganic materials 0.000 description 1
• 235000017550 sodium carbonate Nutrition 0.000 description 1
• 239000011780 sodium chloride Substances 0.000 description 1
• 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
• 229940073490 sodium glutamate Drugs 0.000 description 1
• 229910052938 sodium sulfate Inorganic materials 0.000 description 1
• 235000011152 sodium sulphate Nutrition 0.000 description 1
• 239000002904 solvent Substances 0.000 description 1
• 239000000600 sorbitol Substances 0.000 description 1
• 235000010356 sorbitol Nutrition 0.000 description 1
• 230000009870 specific binding Effects 0.000 description 1
• 239000003381 stabilizer Substances 0.000 description 1
• 230000010473 stable expression Effects 0.000 description 1
• 238000007619 statistical method Methods 0.000 description 1
• 201000011549 stomach cancer Diseases 0.000 description 1
• 208000003265 stomatitis Diseases 0.000 description 1
• 150000008163 sugars Chemical class 0.000 description 1
• 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
• 230000000153 supplemental effect Effects 0.000 description 1
• 239000000829 suppository Substances 0.000 description 1
• 239000004094 surface-active agent Substances 0.000 description 1
• 239000000725 suspension Substances 0.000 description 1
• 230000002459 sustained effect Effects 0.000 description 1
• 208000011580 syndromic disease Diseases 0.000 description 1
• 108010058071 tagatose 1,6-diphosphate aldolase Proteins 0.000 description 1
• 230000008685 targeting Effects 0.000 description 1
• 230000000451 tissue damage Effects 0.000 description 1
• 231100000827 tissue damage Toxicity 0.000 description 1
• 229960000187 tissue plasminogen activator Drugs 0.000 description 1
• 238000011200 topical administration Methods 0.000 description 1
• 230000024033 toxin binding Effects 0.000 description 1
• 230000005029 transcription elongation Effects 0.000 description 1
• 238000012546 transfer Methods 0.000 description 1
• 238000011269 treatment regimen Methods 0.000 description 1
• 239000002753 trypsin inhibitor Substances 0.000 description 1
• 102000003298 tumor necrosis factor receptor Human genes 0.000 description 1
• 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
• 241000701447 unidentified baculovirus Species 0.000 description 1
• 241001529453 unidentified herpesvirus Species 0.000 description 1
• 238000010200 validation analysis Methods 0.000 description 1
• 230000001018 virulence Effects 0.000 description 1
• 238000012800 visualization Methods 0.000 description 1
• 230000029663 wound healing Effects 0.000 description 1
• BPICBUSOMSTKRF-UHFFFAOYSA-N xylazine Chemical compound CC1=CC=CC(C)=C1NC1=NCCCS1 BPICBUSOMSTKRF-UHFFFAOYSA-N 0.000 description 1
• 229960001600 xylazine Drugs 0.000 description 1
• 101150020830 yceM gene Proteins 0.000 description 1
• XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical class [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 description 1